C4 Therapeutics Inc (CCCC)
5.80
+0.04
(+0.69%)
USD |
NASDAQ |
May 22, 16:00
5.79
-0.01
(-0.17%)
After-Hours: 07:56
C4 Therapeutics Total Assets (Quarterly): 398.37M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 398.37M |
| December 31, 2023 | 376.45M |
| September 30, 2023 | 333.01M |
| June 30, 2023 | 375.01M |
| March 31, 2023 | 396.04M |
| December 31, 2022 | 430.84M |
| September 30, 2022 | 461.44M |
| June 30, 2022 | 492.48M |
| March 31, 2022 | 515.48M |
| Date | Value |
|---|---|
| December 31, 2021 | 506.76M |
| September 30, 2021 | 507.91M |
| June 30, 2021 | 528.42M |
| March 31, 2021 | 374.01M |
| December 31, 2020 | 400.14M |
| September 30, 2020 | 229.13M |
| June 30, 2020 | 248.07M |
| December 31, 2019 | 118.26M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
118.26M
Minimum
Dec 2019
528.42M
Maximum
Jun 2021
393.64M
Average
398.37M
Median
Mar 2024
Total Assets (Quarterly) Benchmarks
| Alector Inc | 635.49M |
| CEL-SCI Corp | 30.05M |
| AIM ImmunoTech Inc | 16.19M |
| IGC Pharma Inc | 11.26M |
| NovaBay Pharmaceuticals Inc | 5.357M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 140.09M |
| Shareholders Equity (Quarterly) | 258.28M |
| Current Ratio | 5.082 |
| Net Debt Paydown Yield | 0.41% |